Dimensional Fund Advisors
AURA icon

Dimensional Fund Advisors’s Aura Biosciences AURA Stock Holding History

Dimensional Fund Advisors’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.39M Buy
618,891
+60,733
+11% +$435K ﹤0.01% 2573
2026
Q1 		$3.73M Buy
558,158
+40,242
+8% +$231K ﹤0.01% 2579
2025
Q4 		$2.82M Buy
517,916
+20,641
+4% +$123K ﹤0.01% 2662
2025
Q3 		$3.07M Buy
497,275
+41,118
+9% +$269K ﹤0.01% 2657
2025
Q2 		$2.86M Buy
456,157
+50,231
+12% +$294K ﹤0.01% 2666
2025
Q1 		$2.38M Buy
405,926
+40,102
+11% +$303K ﹤0.01% 2686
2024
Q4 		$3.01M Buy
365,824
+73,062
+25% +$688K ﹤0.01% 2682
2024
Q3 		$2.61M Buy
292,762
+42,387
+17% +$363K ﹤0.01% 2719
2024
Q2 		$1.89M Buy
250,375
+41,711
+20% +$306K ﹤0.01% 2770
2024
Q1 		$1.64M Buy
208,664
+30,946
+17% +$257K ﹤0.01% 2830
2023
Q4 		$1.58M Buy
177,718
+66,178
+59% +$560K ﹤0.01% 2837
2023
Q3 		$1M Buy
111,540
+71,520
+179% +$769K ﹤0.01% 2928
2023
Q2 		$494K Buy
+40,020
New +$428K ﹤0.01% 3064

Other funds holding AURA

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Dimensional Fund Advisors's AURA Position: Q2 2026 in Review

Dimensional Fund Advisors increased its Aura Biosciences (AURA) stake by 11% in Q2 2026, buying an estimated $435K and bringing the position to 618,891 shares worth $4.39M. The position accounts for ﹤0.01% of the portfolio, ranked #2573.

Dimensional Fund Advisors first reported a position in AURA in Q2 2023 and has held it in 13 quarters since. 146 funds tracked by Wall St. Rank hold AURA as of Q2 2026.

  • Dimensional Fund Advisors held 618,891 shares of Aura Biosciences worth $4.39M as of Q2 2026.
  • Dimensional Fund Advisors bought 60,733 Aura Biosciences shares in Q2 2026, an estimated $435K.
  • Aura Biosciences made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q2 2026, its #2573 holding.
  • Dimensional Fund Advisors first reported a position in Aura Biosciences in Q2 2023 and has held it in 13 quarters since.
  • 146 funds tracked by Wall St. Rank held Aura Biosciences as of Q2 2026.

Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.